| Literature DB >> 31911859 |
Zhenna Xiao1,2, Liang Chang1, Jongchan Kim1,3, Peijing Zhang1,4, Qinglei Hang1, Shannon Yap1, Youming Guo1, Zhicheng Zhou1, Liyong Zeng1, Xiaoyu Hu1, Ashley Siverly1, Yutong Sun5, Li Ma1,2.
Abstract
SNAI1, an epithelial-mesenchymal transition (EMT)-inducing transcription factor, promotes tumor metastasis and resistance to apoptosis and chemotherapy. SNAI1 protein levels are tightly regulated by proteolytic ubiquitination. Here, we identified USP37 as a SNAI1 deubiquitinase that removes the polyubiquitination chain from SNAI1 and prevents its proteasomal degradation. USP37 directly binds, deubiquitinates, and stabilizes SNAI1. Overexpression of wild-type USP37, but not its catalytically inactive mutant C350S, promotes cancer cell migration. Importantly, depletion of USP37 downregulates endogenous SNAI1 protein and suppresses cell migration, which can be reversed by re-expression of SNAI1. Taken together, our findings suggest that USP37 is a SNAI1 deubiquitinase and a potential therapeutic target to inhibit tumor metastasis. AJCREntities:
Keywords: EMT; SNAI1; USP37; degradation; deubiquitinase
Year: 2019 PMID: 31911859 PMCID: PMC6943346
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166